Intracranial Recurrence of Carcinoma after Complete Surgical Resection of Stage I, II, and III Non-Small-Cell Lung Cancer

New England Journal of Medicine

Volumn 318, Issue 20, 1988, Pages 1300-1305

  Figlin, Robert A ^a   Piantadosi, Steven ^b   Feld, Ronald ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; BRAIN METASTASIS; HISTOLOGY; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0023914383     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198805193182004     Document Type: Article

References (26)

1. Bunn PA Jr, Nugent JL. Matthews MJ. Central nervous system metastases in small cell bronchogenic carcinoma. Semin Oncol 1978; 5: 314–22.
2. Cox JD, Yesner RA. Adenocarcinoma of the lung: recent results from the Veterans Administration Lung Group. Am Rev Respir Dis 1979; 120: 1025–29.
3. Cox JD, Yesner R, Mietlowski W, Petrovich Z. Influence of cell type on failure pattern after irradiation for locally advanced carcinoma of the lung. Cancer 1979; 44: 94–8.
4. Martini N, Beattie EJ Jr. Results of surgical treatment in stage I lung cancer. J Thorac Cardiovasc Surg 1977; 74: 499–505.
5. Feld R, Rubinstein LV, Weisenberger TH, Lung Cancer Study Group. Sites of recurrence in resected stage I non-small-cell lung cancer: a guide for future studies. J Clin Oncol 1984; 2: 1352–8.
6. Perez CA, Pajak TF, Rubin P, et al. Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy: report by the Radiation Therapy Oncology Group. Cancer 1987; 59: 1874–81.
7. Maurer LH, Tulloh M, Weiss RB, et al. A randomized combined modality trial in small cell carcinoma of the lung: comparison of combination chemotherapy-radiation therapy versus cyclophosphamide-radiation therapy effects of maintenance chemotherapy and prophylactic whole brain irradiation. Cancer 1980; 45: 30–9.
8. Jackson DV Jr, Richards F II, Cooper MR, et al. Prophylactic cranial inadiation in small cell carcinoma of the lung: a randomized study. JAMA 1977; 237: 2730–3.
9. Cox JD, Stanley K, Petrovich Z, Paig C, Yesner R. Cranial irradiation in cancer of the lung of all cell types. JAMA 1981; 245: 469–72.
10. Jacobs RH, Awan A, Bitran JD, et al. Prophylactic cranial irradiation in adenocarcinoma of the lung: a possible role. Cancer 1987; 59: 2016–9.
11. Johnson BE, Becker B, Goff WB, et al. Neurologic, neuropsychologic, and computed cranial tomography scan abnormalities in 2- to 10-year survivors of small-cell lung cancer. J Clin Oncol 1985; 3: 1659–67.
12. Moss HA, Nannis ED, Poplack DG. The effects of prophylactic treatment of the central nervous system on the intellectual functioning of children with acute lymphocytic leukemia. Am J Med 1981; 71: 47–52.
13. Walker RW, Lazar RM, Gralla RJ, Scher HI, Shank B. Neuropsychological abnormalities in long term survivors of small cell lung cancer receiving prophylactic cranial irradiation. Proc Am Soc Clin Oncol 1985; 4: 187. abstract.
14. Mountain CF, Gail MH. Surgical adjuvant intrapleural BCG treatment for stage I non-small cell lung cancer: preliminary report of the National Cancer Institute Lung Cancer Study Group. J Thorac Cardiovasc Surg 1981; 82: 649–57.
15. Holmes EC, Gail M. Surgical adjuvant therapy for stage II and stage III adenocarcinoma and large-cell undifferentiated carcinoma. J Clin Oncol 1986; 4: 710–5.
16. The Lung Cancer Study Group. Effects of postoperative mediastinal radiation on completely resected Stage II and Stage III epidermoid cancer of the lung. N Engl J Med 1986; 315: 1377–81.
17. Manual for staging of cancer 1978. Chicago: American Joint Committee for Cancer Staging and End Results Reporting, 1978:59–64.
18. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–81.
19. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163–70.
20. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. JNCI 1959; 22: 719–48.
21. Cox DR. Regression models and life-tables. J R Stat Soc [B] 1972; 34: 187–220.
22. Johnson RE, Brereton HD, Kent CH. Small-cell carcinoma of the lung: attempt to remedy causes of past therapeutic failure. Lancet 1976; 2: 289–91.
23. Livingston RB, Stephens RL, Bonnet JD, Grozea PN, Lehane DE. Long-term survival and toxicity in small cell lung cancer: Southwest Oncology Group Study. Am J Med 1984; 77: 415–7.
24. Volk SA, Mansour RF, Gandara DR, Redmond J III. Morbidity in long-term survivors of small cell carcinoma of the lung. Cancer 1984; 54: 25–7.
25. Catane R, Schwade JG, Yarr I, et al. Follow-up neurological evaluation in patients with small cell lung carcinoma treated with prophylactic cranial irradiation and chemotherapy. Int J Radiat Oncol Biol Phys 1981; 7: 105–9.
26. Craig JB, Jackson DV, Moody D, et al. Prospective evaluation of changes in computed cranial tomography in patients with small cell lung carcinoma treated with chemotherapy and prophylactic cranial irradiation. J Clin Oncol 1984; 2: 1151–6.